UK MHRA Approves Antibody Cocktail for Covid-19 by AstraZeneca

The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’ has now licensed the […]

Continue Reading